|
|
PROSPECTUS Dated April 12, 2024
|
Pricing Supplement No. 4,743 to
|
PROSPECTUS SUPPLEMENT Dated November 16, 2023
|
Registration Statement Nos. 333-275587; 333-275587-01
|
|
Dated November 26, 2024
|
|
Rule 424(b)(2)
|
$160,000
Morgan Stanley Finance LLC
GLOBAL MEDIUM-TERM NOTES, SERIES A
Senior Notes
Market Linked Notes due December 1, 2027
Based on the Performance of the Common Stock of EQT Corporation
Fully and Unconditionally Guaranteed by Morgan Stanley
The Market Linked Notes due December 1, 2027 Based on the Performance of the Common Stock of EQT Corporation, which we refer to as the notes, are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. Unlike ordinary debt securities, the notes do not pay interest. Instead, if the price of the common stock of EQT Corporation (the “underlying stock”) appreciates or does not depreciate at all over the term of the notes, you will receive for each $1,000 stated principal amount of notes that you hold at maturity an amount in cash equal to the stated principal amount of $1,000 plus the upside payment of $279 per note. However, if the price of the underlying stock depreciates over the term of the notes, you will receive a payment at maturity of only $1,000 per note, without any positive return on the notes. The notes are for investors who are concerned about principal risk but seek an equity-based return and who are willing to forgo current income and returns above the fixed upside payment in exchange for the repayment of principal at maturity plus the possibility of receiving a return of 27.90% per note if the final share price is greater than or equal to the initial share price. The notes are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.
All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These notes are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
•The stated principal amount of each note is $1,000.
•We will not pay interest on the notes.
•At maturity, you will receive for each $1,000 stated principal amount of notes that you hold:
ºIf the final share price is greater than or equal to the initial share price:
$1,000 + the upside payment
ºIf the final share price is less than the initial share price:
$1,000
•The upside payment is $279 per note (27.90% of the stated principal amount).
•We refer to November 26, 2024, the day we price the notes for initial sale to the public, as the pricing date.
•The initial share price is $45.56, which is the closing price of one share of the underlying stock on the pricing date.
•The final share price will equal the closing price of one share of the underlying stock multiplied by the adjustment factor, each as of November 26, 2027, which we refer to as the determination date. The adjustment factor will initially be set at 1.0 and is subject to change upon certain corporate events affecting the underlying stock.
•Investing in the notes is not equivalent to investing in the underlying stock.
•The notes will not be listed on any securities exchange.
•The estimated value of the notes on the pricing date is $986.60 per note. See “Summary of Pricing Supplement” beginning on PS-2.
•The CUSIP number for the notes is 61776WA29 and the ISIN for the notes is US61776WA294.
You should read the more detailed description of the notes in this pricing supplement. In particular, you should review and understand the descriptions in “Summary of Pricing Supplement,” “Final Terms” and “Additional Information about the Notes.”
The notes are riskier than ordinary debt securities. See “Risk Factors” beginning on PS-7.
The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.
PRICE $1,000 PER NOTE
|
|
|
|
|
Price to Public(1)
|
Agent’s Commissions and Fees(2)
|
Proceeds to Us(3)
|
Per Note
|
$1,000
|
$0
|
$1,000
|
Total
|
$160,000
|
$0
|
$160,000
|
(1)The notes will be sold only to investors purchasing the notes in fee-based advisory accounts.
(2)MS & Co. expects to sell all of the notes that it purchases from us to an unaffiliated dealer at a price of $1,000 per note, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per note. MS & Co. will not receive a sales commission with respect to the notes. See “Additional Information About the Notes—Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying prospectus supplement.
(3)See “Additional Information About the Notes—Use of Proceeds and Hedging” on PS-25.
The agent for this offering, Morgan Stanley & Co. LLC, is our affiliate. See “Additional Information About the Notes—Supplemental Information Concerning Plan of Distribution; Conflicts of Interest” in this pricing supplement.
The notes are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
When you read the accompanying prospectus supplement, please note that all references in such supplement to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable.
As used in this document, “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.
MORGAN STANLEY